We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 109.50
Bid: 109.50
Ask: 111.00
Change: 0.00 (0.00%)
Spread: 1.50 (1.37%)
Open: 113.00
High: 113.00
Low: 109.50
Prev. Close: 109.50
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

14 Jul 2020 07:00

RNS Number : 8790S
McBride PLC
14 July 2020
 

14 July 2020

McBride plc

Trading update, Year-end reporting dates, Interim CFO

McBride plc (the "Group"), the leading European manufacturer and supplier of Contract Manufactured and Private Label products for the domestic Household and professional cleaning and hygiene markets, today provides a trading update for the twelve months ended 30 June 2020.

Trading update

The Group anticipates that adjusted operating profit and adjusted profit before tax for the year ended 30 June 2020 will be ahead of current market consensus (*).

Overall, full year revenues from continuing operations at constant currency were 1.7% lower than the previous year. Household sales were flat for the full year with second half year revenues 1.3% higher than the first half year.

As indicated in our 19 May 2020 trading update, second half year trading was stronger than expected, due to increased demand for surface cleaning and dishwashing products in most of our Household markets, and due to encouraging sales of new hand sanitiser products developed by our Aerosols and Asia businesses. This was offset by a reduction in demand for laundry products over the same period. As the pandemic slows in Europe and countries ease restrictions, we have seen customer demand return to more normal levels.

Net debt, excluding IFRS16, closed at circa £93m (30 June 2019: £120.9m). It is expected that the Group will report its banking basis Debt/EBITDA ratio below 1.5x, down from 2.2x at 31 December 2019.

Year-end reporting dates

Following discussions with our statutory auditor and the adverse impact from working under Covid-19 restrictions (which are expected to impact negatively the efficiency of year-end audit and financial reporting activities), the Group intends to announce its preliminary results for the year ended 30 June 2020 on 8 September 2020 on an 'unaudited' basis. At the same time, as planned, the Group will report on progress with its strategy review. We now expect to publish our Annual Report and Accounts in early October and hold our AGM in November 2020. Precise dates will be confirmed on or before 8 September.

Interim CFO

The Group is pleased to announce that Clive Jennings has been appointed as Interim Chief Financial Officer. Clive was formerly CFO at The Rank Group plc and joined McBride in late June. Clive has joined the Group's Executive Committee but has not been appointed to the McBride plc board. The Board has begun a formal process to identify and appoint a permanent CFO.

(*) Current market consensus refers to a Group adjusted PBT of £21.6m compiled following our May trading update.

For further information please contact:

McBride plc

Chris Smith, Chief Executive Officer 0161 203 7570

Clive Jennings, Chief Financial Officer (Interim) 0161 203 7570

 

FTI Consulting 020 3727 1017

Ed Bridges, Nick Hasell

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTVXLFFBDLBBBL
Date   Source Headline
8th Apr 202411:24 amRNSHolding(s) in Company
8th Apr 202411:22 amRNSHolding(s) in Company
5th Apr 20249:53 amRNSHolding(s) in Company
28th Mar 20243:20 pmRNSDirector/PDMR Shareholding
25th Mar 20241:52 pmRNSDirector/PDMR Shareholding
13th Mar 20247:00 amRNSCapital Markets Day
28th Feb 20242:30 pmRNSDirector/PDMR Shareholding
27th Feb 20247:00 amRNSHalf-year Report
16th Jan 20247:00 amRNSTrading Update
13th Dec 20231:47 pmRNSDirector/PDMR Shareholding
20th Nov 20235:55 pmRNSDirector/PDMR Shareholding
20th Nov 20235:39 pmRNSResult of AGM
20th Nov 20237:00 amRNSAGM Trading Update
25th Oct 202310:22 amRNSTermination of ‘upside sharing’ mechanism
19th Oct 20237:00 amRNSTrading Update
17th Oct 20235:42 pmRNSPosting of ARA and Notice of AGM
4th Oct 20235:24 pmRNSVesting of RSU Awards
29th Sep 20237:00 amRNSDirector/PDMR Shareholding
22nd Sep 20235:33 pmRNSDirector/PDMR Shareholding
21st Sep 202310:54 amRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFinal Results
14th Jul 20237:00 amRNSFull year trading update
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
31st May 20235:31 pmRNSDirectorate Change
25th May 20239:38 amRNSDirector Declaration
2nd May 20237:00 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNSTrading Update
11th Apr 20232:08 pmRNSDirector/PDMR Shareholding
3rd Apr 20232:39 pmRNSDirector/PDMR Shareholding
31st Mar 202312:27 pmRNSDirector/PDMR Shareholding
21st Mar 20235:59 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSHalf-year Report
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
1st Feb 20238:46 amRNSDirector Declaration
17th Jan 20237:00 amRNSTrading Update
11th Jan 20239:01 amRNSDirector Declaration
22nd Dec 20224:23 pmRNSDirector/PDMR Shareholding
13th Dec 20222:51 pmRNSDirector/PDMR Shareholding
16th Nov 20224:42 pmRNSAGM Statement
16th Nov 20227:00 amRNSAGM Trading Update
17th Oct 20227:00 amRNSAnnual Report 2022 and Annual General Meeting 2022
5th Oct 20225:55 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:07 pmRNSRedemption of B Shares
29th Sep 202212:49 pmRNSFinal Results
29th Sep 202211:51 amRNSAmended Financing Agreement
29th Sep 20227:00 amRNSPreliminary results timing
6th Sep 20222:51 pmRNSBoard Update
30th Aug 20224:35 pmRNSPrice Monitoring Extension
25th Aug 20226:22 pmRNSCorrection - Result of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.